DEBRA PASCHAL: Open Payments
NPI 1831149319 · GRAY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 68 payments from 14 companies in 2025. Trend: 2023 $2,301 · 2024 $2,269 · 2025 $1,616
Food & beverage: $1,607Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $397 |
| GENZYME CORPORATION | 8 | $253 |
| Lilly USA, LLC | 10 | $227 |
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| LEO Pharma Inc. | 6 | $129 |
| Amgen Inc. | 2 | $108 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| PFIZER INC. | 4 | $89 |
| Organon LLC | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, TALTZ, COSENTYX, OTEZLA, ADBRY, CIBINQO.
Industry payments across GA — which companies pay providers there.
